2016
DOI: 10.1016/j.redar.2015.04.001
|View full text |Cite
|
Sign up to set email alerts
|

Magnesium sulphate and 123I-MIBG in pheochromocytoma: Two useful techniques for a complicated disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2019
2019
2019
2019

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 9 publications
0
3
0
Order By: Relevance
“…All the clinical effects for the use of magnesium sulfate in anesthesia presented by the anesthesiologists participating in this survey have been reported in other publications, including various systematic reviews and meta-analyses, although some of them are still subjects of controversy Beşogul et al, 2009; Gozdemir et al, 2010; Rhee et al, 2012; Abdulatif et al, 2013; Rotava et al, 2013; Agrawal et al, 2014; Ahsan et al, 2014; Crowther et al, 2014; Kahraman and Eroglu, 2014; Kew et al, 2014; Marzban et al, 2014; Rodrigo et al, 2014; Srebro et al, 2014; Uludag et al, 2014; Berhan and Berhan, 2015; Kim et al, 2015; Safavi et al, 2015; Vigil-De Gracia and Ludmir, 2015; Demiroglu et al, 2016; Green, 2016; Griffiths and Kew, 2016; Jangra et al, 2016; Juibari et al, 2016; Maged et al, 2016; Naghipour et al, 2016; Rodríguez-Rubio et al, 2016, 2017; Soltani et al, 2016; Thomas and Behr, 2016; Ulm et al, 2016; Vendrell et al, 2016; Xie et al, 2016, 2017; Brookfield et al, 2017; Haryalchi et al, 2017; Kutlesic et al, 2017; Lecuyer et al, 2017; McKeown et al, 2017; Mendonca et al, 2017; Salaminia et al, 2018; Zhang et al, 2018.…”
Section: Discussionmentioning
confidence: 99%
“…All the clinical effects for the use of magnesium sulfate in anesthesia presented by the anesthesiologists participating in this survey have been reported in other publications, including various systematic reviews and meta-analyses, although some of them are still subjects of controversy Beşogul et al, 2009; Gozdemir et al, 2010; Rhee et al, 2012; Abdulatif et al, 2013; Rotava et al, 2013; Agrawal et al, 2014; Ahsan et al, 2014; Crowther et al, 2014; Kahraman and Eroglu, 2014; Kew et al, 2014; Marzban et al, 2014; Rodrigo et al, 2014; Srebro et al, 2014; Uludag et al, 2014; Berhan and Berhan, 2015; Kim et al, 2015; Safavi et al, 2015; Vigil-De Gracia and Ludmir, 2015; Demiroglu et al, 2016; Green, 2016; Griffiths and Kew, 2016; Jangra et al, 2016; Juibari et al, 2016; Maged et al, 2016; Naghipour et al, 2016; Rodríguez-Rubio et al, 2016, 2017; Soltani et al, 2016; Thomas and Behr, 2016; Ulm et al, 2016; Vendrell et al, 2016; Xie et al, 2016, 2017; Brookfield et al, 2017; Haryalchi et al, 2017; Kutlesic et al, 2017; Lecuyer et al, 2017; McKeown et al, 2017; Mendonca et al, 2017; Salaminia et al, 2018; Zhang et al, 2018.…”
Section: Discussionmentioning
confidence: 99%
“…However, like all beta blockers, concerns exist regarding the risk of paradoxical hypertension in spite of its α1 activity and adverse events have been reported. 6 Other drugs that also have a role are magnesium, 7 sodium nitroprusside and glyceryl trinitrate.…”
Section: Established Endocrine Practicementioning
confidence: 99%
“…In preference to using no alpha blocking agents, clinicians who find themselves in these circumstances should consider using intravenous magnesium for medical stabilisation. 2,6 There is an evidence base for intravenous magnesium 7,8 as an alternative to alpha blockade and importantly the drug is familiar to many intensivists due to its critical role in eclampsia treatment. ■…”
Section: Mechanical Circulatory Support Such As Extracorporeal Membramentioning
confidence: 99%